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Introduction 
Pulmonary alveolar proteinosis (PAP) is a rare disease 
characterized by accumulation of periodic-acid-Schiff 
(PAS)-positive material in the alveolar space (1). Although 
the cause of this disease is unknown, functionally defective 
alveolar macrophages or defective clearance of intra- 
alveolar surfactant re-uptake by type 2 pneumocytes have 
been proposed by some investigators (2,3). In this context, 
PAP has been reported as a complication of certain diseases 
such as tuberculosis, haematological malignancy, inter- 
stitial pneumonitis or AIDS (48). To our knowledge, we 
report the first case of extensively developed PAP coexisting 
with lung squamous cell carcinoma. 
Case Report 
A 67-year-old man was admitted to a local hospital with a 
2-month history of cough, white sputum, dyspnoea and 
fever. Chest X-ray and computed tomography (CT) showed 
a diffuse linear and reticular shadow with a high attenua- 
tion area (crazy-paving appearance) on both sides mainly in 
the lower lung fields. Bronchoalveolar lavage (BAL) and 
transbronchial lung biopsy (TBLB) were performed. Milky 
effluent was obtained on BAL and alveoli were found to be 
filled with PAS-positive lipid on TBLB. These features 
established the diagnosis of PAP. The patient was treated 
with whole lung lavage (WLL) (9) for PAP. However, he 
developed severe hypoxaemia which prevented continua- 
tion of WLL therapy. At that stage, the patient was referred 
to our hospital for continuation of WLL using partial 
extra-corporeal circulation. 
The past history and family history were not remarkable. 
He was a smoker with 2 packs of cigarettes daily for more 
than 40 years, and was a farmer with a negative occu- 
pational history. On physical examination, his height was 
159 cm, body weight 48 kg, and a slight cyanosis was 
observed. Auscultation of the chest revealed fine crackles 
on the lower regions of the chest, bilaterally. The white 
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blood cell (WBC) count was 3600 mm- 3 with 12% eosi- 
nophils. Laboratory tests showed an erythrocyte sedimen- 
tation rate (ESR) of 12 mm h- ‘, and elevated positive 
C-reactive protein (CRP) (1.29 mg dl - ‘), serum IgE 
(1211 U ml - ‘), lactic dehydrogenase (LDH) (935 IU l- ‘) 
and carcinoembryonic antigen (CEA) (41 ng ml - I). Analy- 
sis of arterial blood gases on 10 1 min- ’ 0, showed 
PaO,=10.8 kPa, PaCO,=5.5 kPa and pH=7.379. Chest 
X-ray and CT films taken in May 1994 showed a diffuse 
linear and reticular shadow with a high attenuation area in 
both lung fields together with a small nodular shadow in the 
right S” area (Fig. 1). Whole right lung lavage using partial 
extra-corporeal circulation was performed successfully. The 
symptoms, laboratory tests and blood gas analysis 
improved following this procedure, and chest X-ray and CT 
film also showed a dramatic improvement and resolution of 
the mixed shadow in both lung fields (Fig. 2, top). As part 
of the routine follow-up, we repeated BAL examination, 
which showed a marked reduction of PAS-positive material 
in both lung fields in spite of a limiting whole lung lavage to 
the right side only. However, a single nodular shadow of 
approximately 1 cm in diameter at S” in the right lung was 
observed in June 1994 (Fig. 2, bottom). TBLB was 
performed immediately to examine the nodular lesion. 
Examination of the biopsy material confirmed that the 
lesion was a squamous cell carcinoma. As the malignancy 
was classified as stage 1, right lower lobectomy was per- 
formed. A pathological diagnosis of moderately differenti- 
ated squamous cell carcinoma (T,N,M,, stage 1) with 
residual focal areas of PAP was established. 
Discussion 
We reported a case of PAP with coexisting lung squamous 
cell carcinoma. PAP is a disease of unknown aetiology 
characterized by the deposition of PAS-positive material 
composed of lipid and protein within the alveoli (1). Several 
investigators have reported the presence of dysfunctional 
alveolar macrophages in patients with PAP. Golde and 
co-workers (2) showed that alveolar macrophages obtained 
from lavage fluid of patients with PAP had normal 
phagocytosis but a diminished capacity for killing yeasts. 
They suggested that the abnormal function of alveolar 
macrophages represented an acquired defect since normal 
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FIG. 1. Computed tomography scan of the chest showing 
the diffuse linear and reticular shadow with a high 
attenuation area bilaterally and a small single nodular 
shadow on the S” area of the right lung (bottom). 
FIG. 2. Computed tomography scan of the chest showing 
improvement of the mixed shadows and development 
of a nodular shadow on the S” area of the right lung 
(bottom) after whole right lung lavage using partial 
extra-corporeal circulation. 
peripheral blood monocytes incubated with PAP lavage 
effluent developed morphological abnormalities similar to 
alveolar macrophages recovered from patients with PAP. 
More recent studies by Muller-Quernheim et al. (10) ident- 
ified a protein in the lavage and serum of PAP patients 
capable of inhibiting the respiratory burst of normal blood 
cells. Based on this finding, they postulated that PAP is 
a manifestation of a suppressed function of alveolar 
macrophages. Furthermore, Athanassiadou et al. (11) 
reported that patients with primary lung cancer have a high 
number of functionally incompetent macrophages. They 
suggested that the process of primary lung malignancy 
exerts a local inhibitory effect on macrophages through the 
secretion of a chemical immune inhibitor. Based on these 
earlier studies, it is possible that PAP in our patient 
developed as a result of the initially unidentified lung 
squamous cell carcinoma. 
On the other hand, Friemann et al. (12) have recently 
reported that both alveolar proteinosis and broncho- 
alveolar epithelial hyperplasia may possibly be obligatory 
preconditions for puhnonary tumour development in 
quartz-dust-treated rat lungs, suggesting that an unusual 
injury response to inhaled agents could also enhance 
tumour development. However, such mechanism is unlikely 
to explain the clinical course in our patient since his 
occupational history was negative. Recently, results of 
ultrastructural study have revealed a probable coexistence 
of PAP-type change in the vicinity of non-small-cell lung 
cancer, and it seems probable that the increased disintegra- 
tion and desquamation of type 2 alveolar epithelial cells is 
an indirect cause of this change (13), consistent with the 
oldest theory of Kuhn et al. (14). Since PAP developed 
extensively in our patient, this may partly explain the 
residual focal areas of PAP adjacent to squamous cell 
carcinoma. 
In conclusion, we have described the first case of exten- 
sively developed PAP associated with lung cancer. 
Although it is not yet clear whether the primary cause of 
PAP is the presence of dysfunctional alveolar macrophages, 
our case report indicates that PAP may develop in 
association with lung cancer, in addition to the reported 
association with haematological malignancies. 
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